Clinical Outcomes Using Molecular Prediction in Acute Suspected Sepsis and Infection
brief summary
Sepsis is a complex syndrome that affects the functioning of multiple organ systems and is caused by an uncontrolled response to infection. Sepsis is usually diagnosed with a physical examination and evaluation of symptoms followed by lab tests to look at how different organ systems are functioning and to look for signs of infection, which can take up to 3 days. There aren't currently any tests that allow doctors to predict patient outcome, hospital course, or severity of illness. Our team has identified a set of genes that when combined can predict the likelihood of clinical deterioration; this set of genes is called SEPSET. In this study the investigators will evaluate the predictive capability of SEPSET along with clinical and laboratory measures in patients with suspected infection.
detailed description
The investigators are studying a novel and contemporary paradigm for the management of critically ill patients using molecular (RNA)-based biomarkers to predict clinical deterioration in patients with suspected sepsis.
Building on a successful collaboration with the National Research Council of Canada (NRC), supported by NRC Pandemic Research Challenge Program, by a Natural Sciences and Engineering Research Council of Canada (NSERC) and Canadian Institute of Health Research (CIHR) collaborative grant (CHRP) and Project Grant, our team has developed an RNA-based classifier composed of 4 genes and 2 house-keeping genes (SEPSET) that together, predict the likelihood of clinical deterioration.
In this study, the investigators will prospectively evaluate, compare and combine assessment of the predictive capability of SEPSET, clinical, and laboratory measures to identify patients with suspected sepsis at increased risk for future deterioration, as defined by any of the following: intensive care unit (ICU) admission, initiation of respiratory support (non-invasive ventilatory support), endotracheal intubation, administration of vasopressors/inotropes, or death within the first 72 hours of presentation. Results from SEPSET will be correlated with clinical trajectories evaluated across key clinically relevant endpoints: ventilator liberation, ventilator-free days, duration of mechanical ventilation, ICU length of stay, hospital length of stay, and death at 28-days and 90-days.